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To the Editor: In India, 
buffalopox virus (BPXV), a variant 
of vaccinia virus, is associated 
with severe disease outbreaks 
among buffaloes (1,2), cattle (3), 
and humans in contact with these 
animals (1,4). Most human BPXV 
infections occur in animal attendants 
and milkers (1,4). A similar type 
of vaccinia virus infection has also 
been reported from rural areas 
in Brazil (5). We report a case of 
laboratory-acquired infection with 
BPXV in a researcher in India. 
Clinical signs, symptoms, diagnosis, 
and management of this case 
highlight the need for observance 
and enforcement of strict biosafety 
measures within the laboratory.
A 28-year-old man (researcher) 
who was freeze-drying BPXV isolates 
in a laboratory in Hisar, India sustained 
a cut on his right palm through nitrile 
gloves by accidental piercing of 
shrapnel from a broken ampule. The 
virus being freeze-dried (105.5 50% 
tissue culture infectious doses/mL) was 
isolated from a buffalo in Jalgaon, India, 
in 2010. The injured site on the palm 
was immediately cleaned with 70% 
ethanol and treated with povidone–
iodine solution. No untoward reaction 
was observed <2 days postinjury. 
Erythema appeared at the injury site 
on postinjury day 3. Subsequently, a 
small vesicle developed on postinjury 
day 5 (Figure, panel A). This vesicle 
progressed into a pustule with a central 
area of necrosis by postinjury day 7 
(Figure, panel B). On postinjury day 
9, symptoms worsened (onset of high 
fever and general malaise and pain at 
the affected site), and the researcher 
sought medical care.
Physical examination showed 
high fever (104°F), unilateral axillary 
lymphadenopathy, and edema of the 
palm (Figure, panel C). Amoxicillin (500 
mg, 2×/d), cephalexin (500 mg, 2×/d), 
and analgesic/antipyretic (paracetamol, 
500 mg, 2×/d) were prescribed to 
control secondary complications caused 
by bacterial infection and pain.
The next day, the entire palm 
became cyanotic and edema increased 
(Figure, panel D). The researcher was 
then referred to a specialty hospital 
where the lesion was surgically excised 
on postinjury day 11 (Figure, panel E) 
under axial block anesthesia. Blood, 
necrotic tissue, pustular material, and 
swab specimens were obtained for 
laboratory examination. Postsurgery 
treatment included cleaning of the 
surgical site on alternate days and 
oral medication (amoxicillin/clavulanic 
acid, 625 mg; ibuprofen, 400 mg; 
paracetamol, 325 mg; and rabeprazole, 
20 mg) for 5 days.
On postinjury day 19, the surgeon 
advised the patient to take cefuroxime 
(500 mg/d for 5 days) and use a topical 
ointment containing mupirocin to 
prevent a delay in healing (Figure, 
panel F). The lesion healed slowly, and 
by postinjury day 30, thickening and 
blackening of the skin was observed 
(Figure, panel G) that extended to 
a wider area by postinjury day 38, 
and the skin started to peel off by 
postinjury day 50. The entire skin of 
the palm sloughed off with complete 
healing by postinjury day 85, leaving 
a 20-mm blackened eschar over the 
area (Figure, panel H).
Clinical samples were subjected 
to laboratory examination. Virus was 
isolated from tissue samples in a Vero 
cell line during the first passage. BPXV 
infection was confirmed by PCR 
amplification of orthopoxvirus-specific 
A type inclusion gene (552 bp) and a 
BPXV-specific C18L gene (368 bp) 
from tissue material and the laboratory-
isolated virus (BPXV/Human/Lab/11), 
according to procedures described by 
Singh et al. (6). Sequences of these 
2 genes were submitted to GenBank 
under accession nos. JN653284.1 and 
JN653278.1, respectively. Phylogenetic 
analysis showed 95%–100% nt 
similarity of the laboratory isolate 
(BPXV/Human/Lab/11) with other 
BPXVs from India (online Technical 
Appendix Figure, wwwnc.cdc.gov/EID/
article/20/2/13-0358-Techapp1.pdf). 
Antibodies against BPXV were detected 
in patient serum samples by using an 
indirect immunoperoxidase test and a 
50% plaque-reduction neutralization 
test according to methods reported by 
Bera et al. (7). Serum of the infected 
patient showed 50% plaque-reduction 
neutralization test titers of 256 and 
512 on postinjury days 11 and 28, 
respectively. These findings confirmed 
BPXV infection because the patient had 
not been vaccinated against smallpox.
Pre-freezing of the glass ampule 





the glass. The ampule broke while 
being introduced into the freeze-
drying manifold and pierced the palm 
of the researcher. As a follow-up 
measure, the freeze drying procedure 
was reviewed and the pre-freezing 
temperature was reduced to –60°C. 
Measures were also taken to ensure 
use of better-quality ampules. Surgical 
and contact material associated with 
the lesion was placed in biohazard 
bags for autoclaving before disposal. 
In addition, laboratory and hospital 
staff was apprised of the risk associated 
with BPXV transmission.
Reporting of laboratory-acquired 
infections is crucial because infections 
could also spread to other personnel. 
Strict biosafety practices and laboratory 
guidelines are useful in minimizing lab-
oratory-acquired infections. Guidelines, 
no matter how stringent, are not suffi-
cient on their own. Laboratory-acquired 
infections occur because humans or ma-
chines are not infallible. Thus, laborato-
ries should have emergency procedures 
in place to deal with such situations.
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To the Editor: Rabies is caused by 
12 recognized virus species within the 
Lyssavirus genus (family Rhabdoviri-
dae) (1) and each year causes 55,000 
deaths worldwide among humans. In 
Europe, the main reservoir and vec-
tor of rabies is the red fox (Vulpes 
vulpes), followed by the raccoon dog 
(Nyctereutes procyonoides) in central 
and Baltic Europe (2). Among these 
virus species, the rabies virus (former 
genotype 1, classical rabies virus) is 
maintained in reservoir mammals, 
mainly carnivores. Despite the suc-
cessful oral vaccination campaigns of 
wildlife that eliminated rabies in large 
parts of Europe (2), the disease still oc-
curs in Europe; 4,884 cases in animals 
were recorded in 2012.
Until 2012, Greece had been free 
of rabies since 1987; the last case oc-
curred in a dog. During 1971–1987, 
a total of 248 cases were recorded in 
domestic animals, of which only 6 
occurred during 1981–1987 (3). The 
wide compulsory vaccination of dogs, 
along with control of stray dogs, were 
the main measures leading to the elim-
ination of rabies in Greece.
Greece shares land borders with 
Turkey, Former Yugoslav Republic 
of Macedonia (FYROM), and Bul-
garia, where rabies is reported in 
wild and domestic animals (4; www.
who-rabies-bulletin.org/). After the 
fox rabies case reported in FYROM 
in 2011, ≈0.3 km from Greece (4), ra-
bies surveillance was improved along 
the northern and eastern land borders 
of Greece, and wild and domestic ani-
mals found dead or suspected of hav-
ing rabies were collected. This pro-
gram was approved by the European 
Commission. The first rabies case was 
diagnosed on October 19, 2012, in a 
red fox in Palaiokastro, 60 km from 
the Albanian border. The animal was 
wandering in the village during day-
time and attacked a dog before being 
killed by local hunters and sent to the 
National Reference Laboratory for 
Animal Rabies (Athens, Greece) for 
rabies testing. The second case, iso-
lated in Ieropigi, 4 km from the Alba-
nian border, was a shepherd dog dem-
onstrating aggressive behavior against 
dogs and sheep of the flock. Seven 
additional cases (6 foxes, 1 dog) were 
reported in December 2012 in 2 pre-
fectures of northern Greece that share 
borders with FYROM (5).
In 2012, a total of 237 domestic 
and wild animals were submitted to 
the National Reference Laboratory 
for Animal Rabies for rabies testing. 
Samples were tested by the fluores-
cent antibody test, rabies tissue cul-
ture infection test, real-time reverse 
transcription PCR, and heminested 
reverse transcription PCR, as de-
scribed (6,7). In brief, viral RNA was 
extracted (Viral RNA Mini Kit, QIA-
GEN, Hilden, Germany) from 140 μL 
of homogenized brain suspension su-
pernatant and subjected to the partial 
nucleoprotein (N) gene amplification 
(positions 71–644 compared with PV 
strain genome). The PCR products 
were bidirectionally sequenced by us-
ing the same primers in a 3130xl Ge-
netic Analyzer (Applied Biosystems, 
Foster City, CA, USA). The phyloge-
netic tree was constructed by using the 
neighbor-joining method with 1,000 
replicates using MEGA5 (8).
Of 237 animals tested, 9 (7 foxes, 
2 dogs) were rabies positive by fluo-
rescent antibody test, rabies tissue cul-
ture infection test, and PCR. Positive 
samples were subjected to sequencing 
analysis of the N gene. The sequence 
analysis of the first 567 nt of the N 
gene of the 3 isolates (GR64C/12, 
GR112C/12, GR238C/12) showed 
99.8% nt identity with the N gene of 
a rabies virus (GenBank accession no. 
JQ973884) isolated from a red fox in 
FYROM in 2011. Nucleotide identity 
was 100% between the 6 isolates from 
Greece (GR177C/12, GR187C/12, 
GR217C/12, GR231C/12, GR236C/12, 
GR242C/12) and isolate JQ973884, as 
well as a Serbia strain (GenBank ac-
cession no. JF973785). This perfect 
nucleotide identity shown with the 
Serbia isolate collected >15 years ago 
suggests the persistence of some viral 
strains over time in the Balkans, in ac-
cordance with previous studies (4,9). 
Amino acid identity was perfect among 
all 9 isolates from Greece.
Phylogenetic analysis of the 
partial sequences of the N gene 
of isolates from Greece compared 
with representative sequences from 
the Balkans (Figure) showed that 
isolates from Greece resolved within 
the East Europe (EE) group of the 
cosmopolitan lineage. The EE group 
encompasses the 9 Greek isolates 
with referenced viral sequences from 
FYROM, Bulgaria, Serbia, Bosnia 
Herzegovina, and Montenegro. With-
in the EE group, <1.5%-nt divergence 
exists between all analyzed N gene 
sequences (567 nt).
The perfect nucleotide identity 
shown between the 6 isolates from 
Greece and 2 strains from Serbia and 
FYROM demonstrates a close genetic 
relationship between them. This find-
ing supports the hypothesis of move-
ment of rabies-infected hosts in the 
western Balkan countries.
Greece was rabies free for 25 years. 
In the 2012 outbreak, the rabies cycle 
appears to be sylvatic, whereas until 
1987, dogs were the main reservoir 
of rabies. Measures including public 
awareness campaigns and intensified 
vaccination of stray animals and shep-
herd dogs, combined with control of 
stray dogs and cats, already have been 
implemented. In accordance with the 
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